LyGenesis Announces a New Peer-Reviewed Publication Expanding its Liver Regeneration Technology

/PRNewswire/ -- LyGenesis, a clinical-stage biotechnology company developing cell therapies for patients with end stage liver disease, Type 1 diabetes, end...

Related Keywords

Pennsylvania ,United States ,Amin Cheikhi ,Bing Han ,Ruoyu Chen ,Joycelyn Johnson ,Fei Chen ,Maria Giovanna Francipane ,Jacqueline Jeha ,Eric Lagasse ,David Roblin ,Mcgowan Institute For Regenerative Medicine ,Longevity Vision Fund ,Lygenesis Inc ,Department Of Pathology ,University Of Pittsburgh ,Fat Associated Lymphoid Clusters ,Expandable Niches ,Ectopic Liver Development ,Chief Scientific Officer ,Associate Professor ,Mcgowan Institute ,Regenerative Medicine ,Juvenescence Therapeutics ,Lygenesis ,